Topics

"Dietary vulnerability found cancer cells with mutated spliceosomes" Drugs and Medication Database: Page 6

11:14 EST 25th February 2020 | BioPortfolio

Here are the most relevant "Dietary vulnerability found cancer cells with mutated spliceosomes" Drugs and Medications that we have found in our database.

More Information about "Dietary vulnerability found cancer cells with mutated spliceosomes" on BioPortfolio

We have published hundreds of Dietary vulnerability found cancer cells with mutated spliceosomes news stories on BioPortfolio along with dozens of Dietary vulnerability found cancer cells with mutated spliceosomes Clinical Trials and PubMed Articles about Dietary vulnerability found cancer cells with mutated spliceosomes for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dietary vulnerability found cancer cells with mutated spliceosomes Companies in our database. You can also find out about relevant Dietary vulnerability found cancer cells with mutated spliceosomes Drugs and Medications on this site too.

Showing "Dietary vulnerability found cancer cells with mutated spliceosomes" Drugs and Medications 126–127 of 127

Possibly Relevant

Infugem [sun pharmaceutical industries, inc.]

These highlights do not include all the information needed to use INFUGEM safely and effectively. See full prescribing information for INFUGEM.   INFUGEM (gemcitabine in sodium chloride injection), for intravenous use Initial U.S. Approval: 1996  

Fludeoxyglucose f 18 [hamamatsu/queen’s pet imaging center, llc]

Fludeoxyglucose F 18 Injection, USP, For Intravenous Use



Quick Search